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 ABSTRACT 
 The clinical beliefs (expectations and demands) of 
veterinarians regarding herd-level strategies to control 
mastitis, lameness, and Johne’s disease were quanti-
fied in a numerical format; 94 veterinarians working 
in England (UK) were randomly selected and, during 
interviews, a statistical technique called probabilistic 
elicitation was used to capture their clinical expecta-
tions as probability distributions. The results revealed 
that markedly different clinical expectations existed for 
all 3 diseases, and many pairs of veterinarians had ex-
pectations with nonoverlapping 95% Bayesian credible 
intervals. For example, for a 3-yr lameness intervention, 
the most pessimistic veterinarian was centered at an 
11% population mean reduction in lameness prevalence 
(95% credible interval: 0–21%); the most enthusiastic 
veterinarian was centered at a 58% reduction (95% 
credible interval: 38–78%). This suggests that a major 
change in beliefs would be required to achieve clinical 
agreement. Veterinarians’ clinical expectations were 
used as priors in Bayesian models where they were 
combined with synthetic data (from randomized clini-
cal trials of different sizes) to explore the effect of new 
evidence on current clinical opinion. The mathematical 
models make predictions based on the assumption that 
veterinarians will update their beliefs logically. For ex-
ample, for the lameness intervention, a 200-farm clinical 
trial that estimated a 30% mean reduction in lameness 
prevalence was predicted to be reasonably convincing 
to the most pessimist veterinarian; that is, in light of 
this data, they were predicted to believe there would be 
a 0.92 probability of exceeding the median clinical de-
mand of this sample of veterinarians, which was a 20% 
mean reduction in lameness. Currently, controversy ex-
ists over the extent to which veterinarians update their 
beliefs logically, and further research on this is needed. 
This study has demonstrated that probabilistic elicita-
tion and a Bayesian framework are useful for evaluat-
ing the diversity and strength of veterinarians’ clinical 
beliefs. The wide variations observed have implications 
for designing future projects. Although many factors 
influence disease control, nonetheless the heterogeneity 
in beliefs also raises concern over the extent to which a 
broadly consistent approach is currently being achieved; 
it supports the argument for more randomized clinical 
trials and for national programs to control nonstatu-
tory endemic diseases. 
 Key words:   evidence-based medicine ,  Bayesian up-
dating ,  clinical belief ,  probabilistic elicitation 
 INTRODUCTION 
 In the United Kingdom, most major endemic dis-
eases of cattle are not under statutory control and 
hence the health of the national herd is critically reliant 
on farmers and their advisors. The clinical beliefs held 
by veterinarians working in private practice are thus 
important because they underpin the advice provided 
to farmers, the decisions that are made, and the way 
in which new research evidence is interpreted and ap-
plied. If new research is to have any effect it must be 
capable of changing veterinarians’ current beliefs, and 
ultimately those of the farmers, otherwise it risks being 
of limited value and will not deliver a cost beneficial re-
turn on the investment necessary to conduct the work. 
 If the unknown parameter of interest, say θ, is de-
fined as the effect of a specified treatment (or disease 
intervention), then a veterinarian’s clinical expectations 
regarding θ pertain to the possible values they believe θ
will take, based on their current clinical experiences and 
knowledge (i.e., their beliefs, which includes informa-
tion and influences from all possible sources). Within 
a Bayesian statistical framework, clinical expectations 
can be expressed in a numerical format as a probability 
distribution, using a statistical technique called proba-
bilistic elicitation (O’Hagan et al., 2006). Once expec-
tations are captured as probability distributions, it is 
possible to quantitatively study the variation in clinical 
expectations, and to explore, using Bayesian statisti-
cal models, the response of veterinarians with different 
clinical expectations to new information (Parmar et al., 
1994). For a single continuous unknown parameter, θ, 
Bayes theorem can be written as
 Quantifying veterinarians’ beliefs on disease control and exploring 
the effect of new evidence: A Bayesian approach 
 H. M.  Higgins ,*1  J. N.  Huxley ,†  W.  Wapenaar ,† and  M. J.  Green †
 * Faculty of Health and Medical Sciences, School of Veterinary Medicine, Guildford, University of Surrey, GU2 7TE, United Kingdom 
 † University of Nottingham, School of Veterinary Medicine and Science, Sutton Bonington Campus, Leicestershire, LE12 5RD, United Kingdom 
 
  
 Received May 31, 2013.
 Accepted February 12, 2014.
 1 Corresponding author:  h.higgins@surrey.ac.uk 
Open access under CC BY-NC-ND license.
Journal of Dairy Science Vol. 97 No. 6, 2014
QUANTIFYING BELIEFS AND BAYESIAN UPDATING 3395
 π(θ|x) v π(x|θ) π(θ),  [1]
where, in the context of this paper, π(θ) is the vet-
erinarian’s current clinical expectation for θ, expressed 
as a probability distribution; π(x|θ) is the likelihood 
function (based on new synthetic data, x); and π(θ|x) is 
the posterior probability distribution that encapsulates 
everything that is now known about θ, having updated 
the veterinarian’s current clinical expectation with the 
new information contained in the data. In Bayesian 
terminology, π(θ) is referred to as the prior. Equation 
[1] states that the extent of any logical change in be-
lief depends on both the current clinical expectation 
π(θ) and the strength of the new evidence π(x|θ); thus, 
Bayes theorem quantifies (probabilistically) how new 
data should, logically, influence pre-existing expecta-
tions about an uncertain parameter.
Clinical expectations have been probabilistically 
elicited in human medicine and to a lesser extent in 
veterinary medicine (O’Hagan et al., 2006). In ad-
dition, at the same time as eliciting doctors’ clinical 
expectations, some studies have elicited doctors’ “clini-
cal demands,” θmin. A new treatment almost invariably 
carries economic and other costs (e.g., adverse reac-
tions, toxicity, or drug resistance). As a result, doctors 
usually demand that a “minimum clinically worthwhile 
effect” (i.e., θmin) must be achieved in order for them to 
consider the treatment worthwhile implementing when 
compared against alternative approaches. Eliciting a 
clinical demand requires a doctor to weigh all the po-
tential advantages and disadvantages of the treatment 
and assign a single value (or range of values) to θmin 
(Parmar et al., 1994). To our knowledge, clinical de-
mands have not been elicited from veterinarians work-
ing in farm animal medicine.
In a Bayesian analysis (Equation [1]), θmin can be 
juxtaposed on the posterior distribution π(θ|x), and the 
null hypothesis (no treatment effect) is rejected in favor 
of the alternative hypothesis (θ > θmin) when the poste-
rior distribution assigns a “sufficiently large” probabil-
ity to θ taking values greater than θmin(Spiegelhalter 
et al., 2004). This probability, denoted here by λ, is a 
subjective choice but “sufficiently large” is often taken 
to be λ ≥ 0.95. The choice for λ affects when the trial 
is stopped and the larger the value of λ, the greater 
the probability that the minimum clinically worthwhile 
effect will be realized.
In a retrospective Bayesian analysis, a recent study 
used a range of theoretical clinical expectations (priors) 
aimed at representing different opinions (from “severely 
skeptical” to “very enthusiastic”) to model the effect of 
a clinical mastitis trial (Green et al., 2009). The study 
explored how the results of the trial would be inter-
preted by veterinarians with theoretically constructed 
different initial beliefs and predicted that important dif-
ferences in opinion would exist in light of the evidence. 
However, to the authors’ knowledge, no studies have ac-
tually quantified veterinarians’ clinical expectations or 
demands concerning herd-level interventions to reduce 
the endemic diseases of cattle. This omission is striking 
because, in analogy with human medicine (Spiegelhal-
ter et al., 2004), a potentially important obstacle to the 
widespread implementation of veterinary interventions 
on farms may relate to the variability of veterinarians’ 
beliefs concerning the effectiveness of disease control 
measures. If veterinarians currently have very different 
clinical expectations, then other approaches, such as 
more convincing research evidence, will be required to 
alter these beliefs. Although this is not to say that it 
is only research evidence that influences what veteri-
narians believe. Our hypothesis was that demonstrable 
variation exists for veterinarians’ clinical expectations 
and demands regarding mastitis, lameness, and Johne’s 
disease.
The first objective of this study was to report a 
probabilistic elicitation that aimed to quantify the 
current variation in veterinarians’ clinical expectations 
and demands with respect to herd-level interventions to 
reduce mastitis, lameness, and Johne’s disease in dairy 
cattle. The second objective was to explore, within 
a Bayesian statistical framework, the implications of 
the heterogeneity in beliefs. This was done by using 
a mathematical model to make predications regarding 
how new evidence will alter what veterinarians cur-
rently believe. The model makes the assumption that 
veterinarians will update their beliefs logically.
MATERIALS AND METHODS
Recruitment of Veterinarians
It was of interest to compare the beliefs of veteri-
narians with and without postgraduate qualifications. 
However, without some targeted selection, it was pos-
sible that no veterinarians holding postgraduate quali-
fications would be included in the sample. Therefore, 
to be eligible for selection, veterinarians must have 
been currently providing healthcare to dairy cattle in 
England during their normal working hours and be em-
ployed by a veterinary practice that contained at least 
one veterinarian possessing a postgraduate cattle quali-
fication; that is, the European College of Bovine Health 
Management Diploma, the Royal College of Veterinary 
Surgeons Certificate or Diploma in Cattle Health and 
Production, or the University of Liverpool Diploma in 
Bovine Reproduction. None of the veterinarians were 
exclusively involved in providing emergency care or 
consultancy.
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A 2-stage cluster design stratified by geographic loca-
tion was used. First, 20 practices were selected with 
probability proportional to the number of veterinarians 
they contained. Subsequently, if the practice had >5 
eligible members, then 5 were selected using the random 
number generator function in the software program R 
version 2.15.2 (R Core Team, 2012). In practices that 
contained ≤5 eligible participants, all veterinarians 
were recruited. This sampling strategy meant that ev-
ery veterinarian had approximately the same chance 
of selection, independent of the size of the practice in 
which they worked (Kalton, 1987). The Royal College 
of Veterinary Surgeons online database (http://www.
rcvs.org.uk/) provided a list of veterinary practices. 
Face-to-face, individual interviews were conducted by 
H.M.H. between June 8 and September 1, 2011. Veteri-
narians were provided with an inconvenience allowance 
of £100/h (pro rata). A standard script was used for 
consistency, and basic descriptive information concern-
ing the veterinarians was gathered.
Clinical Expectations
We examined 3 epistemic parameters of interest (θm, 
θl, θj), each of which related to the population mean 
effect of an intervention strategy aimed at reducing an 
endemic disease. The subscript refers to the endemic 
disease, such that θm was defined as the population mean 
effect of a 1-yr mastitis intervention, θl a 3-yr lameness 
intervention, and θj an 8-yr Johne’s disease intervention. 
In addition, θd is used to refer more generally to the 
population mean effect of a disease intervention (d = m, 
l, j). For each disease, what was meant by “an interven-
tion strategy” was described to each participant in detail 
(see Appendix) and can be summarized as follows. For 
all 3 diseases, an initial assessment of any available farm 
data was conducted, in conjunction with a farm visit, 
to assess the risks and achieve a working diagnosis. For 
mastitis and Johne’s disease, the initial assessment was 
additionally taken to include some strategic laboratory 
testing, and for lameness, some locomotion scoring. As 
a result, a list of farm-specific recommendations was 
made, based on current best evidence where possible, 
prioritized, and discussed with the farmer. During 
quarterly farm revisits, the farm data and risks were 
reassessed, allowing the control measures to be modified 
in a timely manner, and encouragement and support 
were provided to implement the control measures. Note, 
that in the UK, uncomplicated cases of mastitis and 
lameness are often diagnosed and treated initially by 
farm personnel, following a standard protocol agreed 
with their veterinarian.
Different time periods were chosen for the interven-
tions and these reflect the fact that the time taken to 
make clinically observable reductions in disease levels 
varies with the disease. For the task, it was assumed that 
all dairy farms in England had been recently visited by 
their local veterinarian to discuss the disease in ques-
tion. The population under consideration was all the 
farmers who, following this consultation, subsequently 
decided to proceed with the disease intervention
The disease outcomes were as follows. For the masti-
tis intervention, it was assumed that in the year before 
and in the year after the intervention took place, the 
number of clinical cases of mastitis per 100 cows was 
reliably measured for each farm in the population, to 
calculate the population mean mastitis incidence before 
and after the intervention; subclinical mastitis was not 
considered. For lameness, it was assumed that for each 
farm in the population, the entire dairy herd was reli-
ably scored for lameness at the start of the intervention 
and then again at the end, to determine the population 
mean prevalence of lameness; lame was defined as ob-
servably lame in one or more limbs, with any severity 
of limp. For Johne’s disease, it was assumed that for 
each farm in the population all the adult cattle (≥24 
mo old) were blood sampled before and after the inter-
vention and the percentage of blood-test-positive adults 
was used as an approximation for the population mean 
prevalence of Johne’s disease; it is acknowledged that 
this is an estimate because of the limited sensitivity of 
the test. These outcomes were chosen because veteri-
narians were likely to be familiar with them. The popu-
lation mean outcome before and after the intervention 
are denoted ψd
0 and ψd
1, respectively. As before, subscript 
d refers to the endemic disease (d = m, l, j).
The scale used was the difference in the population 
mean outcome (before and after the intervention) 
divided by the population mean outcome before the 
intervention, expressed as a percentage:
 θd
d d
d
d=
−
× >
ψ ψ
ψ
ψ
0 1
0
0100 0, .  [2]
Hence, θd ∈ −∞ +[ ], 100  for d = m, l, j. On this scale, 
positive percentages reflect reductions in disease and 
negative percentages reflect increases in disease. Thus, 
for example, θl = 20% is a 20% reduction in lameness 
prevalence, averaged across all farms, with a 3-yr lame-
ness intervention. Veterinarians’ expectations for θd 
were elicited using a method that enabled probability 
distributions to be fitted to their answers (see next sec-
tion).
The 3 parameters (θd) were elicited conditional on 
the assumption that without an intervention delivered 
with the help of a veterinarian, the change in popula-
tion mean over the time period would be zero for each 
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disease. In addition, despite the fact that the popula-
tion parameters related to farmers who had volunteered 
to participate with the intervention, it was possible 
that some farmers may not actually implement any 
of the recommendations either at all or to a sufficient 
standard, such that their intervention had no chance 
of having any effect at all. Therefore, veterinarians 
were asked to provide a single estimate for the per-
centage of farmers who would fall into this category 
of zero implementation for each disease. Veterinarians 
were told to exclude these farmers from the population 
under consideration when they made their estimates 
for θd; however, it was also stated that even with this 
exclusion, there was likely to remain a wide diversity in 
the scale and effectiveness of farmer implementation.
In summary, veterinarians’ beliefs were sought for 
the expected (future) outcome of the specified disease 
intervention, on average, across all farms who imple-
mented at least some of the recommendations (θd). For 
example, for the 8-yr Johne’s program, θj documents 
veterinarians’ beliefs regarding the final outcome of this 
intervention, given that it commenced today.
Probabilistic Elicitation Method
The fixed-interval method was used, such that for 
each parameter (θd), 5 values were elicited to allow 
a probability distribution to be fitted: the minimum 
and maximum values, median, and lower and upper 
quartiles. The minimum and maximum values for 
the parameter together constituted a plausible range, 
such that the veterinarian considered it “exceedingly 
unlikely” that the actual answer would fall outside this 
range. The order in which these values are elicited is 
important to avoid an anchoring and adjustment heu-
ristic; thus, the plausible range was elicited first so that 
further judgments were made relative to this range. If, 
for example, the median were elicited first, then there 
would be a tendency for this to act as an anchor, and 
the maximum and minimum values may not be ad-
justed far enough away from the median (O’Hagan et 
al., 2006).
Current best practice for probabilistic elicitation was 
used, whereby a face-to-face interview between the first 
author and each veterinarian was conducted at the 
veterinarian’s own place of work and lasted between 70 
and 100 min. The first part of the elicitation involved a 
15- to 25-min training exercise, whereby the scale upon 
which veterinarians needed to give their answers was 
explained, as well as the meaning of the 5 judgments 
they needed to make, using a fictitious example of a 
veterinarian who was convinced that an unspecified 
disease intervention would certainly make the disease 
problem worse (Parmar et al., 1994). This example was 
used on the grounds that the majority of veterinarians 
would believe that the disease interventions in ques-
tion would typically reduce disease, and therefore the 
example explained how they should give their answers 
but avoided biasing them toward a certain disease 
reduction. It is also worth noting that during their in-
terviews the veterinarians were asked for their current 
clinical expectations and in particular, they were not 
shown any data pertaining to any of the parameters, θd.
The Sheffield Elicitation Framework is a freely avail-
able package of guidance documents, templates, and 
software specifically designed for carrying out proba-
bilistic elicitation (SHELF; http://www.tonyohagan.
co.uk/shelf/). Probability distributions were fitted to 
the veterinarians’ 5 judgments using computer code 
provided with this package (SHELF version 1.01) and 
run in the software program R, version 2.15.2 (R Core 
Team, 2012). The probability distributions were fitted 
during the interviews and graphically presented to each 
veterinarian. Furthermore, some of the inferred, but 
not directly elicited, probabilities were cited to them; 
this enabled veterinarians to visualize their answers and 
gave them the opportunity to revise their 5 judgments 
appropriately until they felt the fitted distributions 
were a fair reflection of their beliefs.
Clinical Demands
For each disease, veterinarians were asked to weigh 
all the benefits of implementing the intervention on 
many thousands of farms, against all the costs (see 
Appendix). The minimum population mean reduction 
they would want the intervention to deliver, to consider 
the intervention clinically worthwhile implementing on 
a large scale, is subsequently referred to as their “’clini-
cal demands” (θd
min, d = m, l, j). Veterinarians were 
asked to either give a single value or, if they preferred, 
a range of values.
In addition, for each disease intervention, veterinar-
ians were asked to give a value for λ:  λd, d = m, l, 
j. That is, they were asked for the probability (as a 
percentage chance) that the actual mean reduction in 
disease would be greater than what they had stated 
was a minimally clinically worthwhile effect. This value 
for λ was placed in the context of the veterinarian need-
ing to be “convinced that the disease intervention is 
clinically useful and worthwhile implementing on many 
farms,” based on the evidence produced by a clinical 
trial alone.
The purpose of eliciting λ was to explore any differ-
ences between veterinarians in terms of the strength of 
evidence needed to be convincing to them. However, 
this is not to say that it is only evidence from clini-
cal trials that influences how convinced veterinarians 
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are regarding the outcome of a disease intervention in 
reality. Many factors (e.g., marketing campaigns, clini-
cal experience, farmer experience, colleagues) can have 
an effect. It was beyond the scope of this project to 
quantify and mathematically model the influence of 
all possible factors. However, because it is hoped that 
new evidence has some influence on veterinarians’ con-
fidence in the usefulness of disease interventions, it is 
of interest to know how veterinarians differ in terms of 
the strength of evidence they would like to be presented 
with; by eliciting λ, this is what our study has focused 
on.
The study was approved by the Research and Ethics 
committee, School of Veterinary Medicine and Science, 
University of Nottingham.
Data Analysis
Due to the scale involved; that is, θd ∈ −∞ +[ ], ,100  a 
suitable choice was to fit normal (Gaussian) probability 
density functions to the 5 elicited values for θm, θl, and 
θj, for each veterinarian. The normal family of probabil-
ity density functions is characterized by 2 parameters: 
the mean and the variance. In keeping with Bayesian 
terminology, these are referred to as “hyperparameters” 
to distinguish them from the elicited (population) pa-
rameters. The R code provided in SHELF was used to 
find the best fitting hyperparameters by minimizing 
the sum of the squared differences between the fitted 
cumulative distribution and the elicited cumulative 
distribution; this uses numerical optimization based on 
the simplex algorithm (Nelder and Mead, 1965). In ad-
dition for each disease, the 5 raw elicited values were 
each arithmetically averaged (across the veterinarians), 
and a normal distribution fitted to these 5 averaged 
numbers; for each disease, this distribution will be re-
ferred to as the “clinical expectations for the average 
veterinarian.” It should be noted that this is a theo-
retical concept because it is unlikely to represent the 
actual belief of any individual person.
Visualizing the Diversity in Clinical Opinion 
for θd. To illustrate the diversity in clinical expec-
tations among the sample of veterinarians for each 
disease, 3 different individuals were identified: (a) the 
most ambivalent, (b) the most pessimistic, and (c) the 
most enthusiastic. Veterinarian (a) was identified based 
on the widest plausible range for θd, veterinarians (b) 
and (c) were identified based first on the lowest and 
highest median belief for θd, respectively, and then if 
tied results existed (e.g., two or more veterinarians 
had the same highest median belief) the veterinarian 
was selected that had the narrowest plausible range. 
In other words, “enthusiasm/pessimism” was based on 
center of location, and if more than one veterinarian was 
centered in the same enthusiastic or pessimistic place, 
then the most confident veterinarian was selected.
Modeling the Implications of the Heterogene-
ity in Clinical Beliefs. The clinical expectations of 
the most enthusiastic and pessimistic veterinarians were 
used as priors in a Bayesian analysis to predict how 
their current clinical expectations would be updated in 
the light of new data, as follows. The prior belonging 
to each veterinarian was combined using Bayes theorem 
(Equation [1]) with synthetic data originating from a 
randomized clinical trial to produce a posterior distri-
bution for each veterinarian. This posterior distribution 
can be considered to represent what each veterinarian 
would believe if they were shown the data and updated 
their current clinical expectations logically in accor-
dance with Bayes theorem.
For the Bayesian analysis, it was necessary to specify 
a likelihood function (i.e., to probabilistically specify 
the new information about θd arising from an experi-
ment). For each disease, a clinical trial was assumed to 
have been conducted and designed such that farms 
were randomly assigned to 1 of 2 groups (control and 
intervention) with n farms in each group. The control 
farms received no intervention. For all farms enrolled in 
the trial, in the year before and after the intervention 
the clinical outcome was measured (as previously de-
scribed), and from this information the sample mean 
change in disease was calculated for the control and 
intervention farms (in analogy with Equation [2]) and 
denoted yc and yd , respectively. Assuming independent 
random observations, then by virtue of the central 
limit theorem,
 y N
n
yc N nd d
d
c
d≈
⎛
⎝
⎜⎜⎜⎜
⎞
⎠
⎟⎟⎟⎟⎟
≈
⎛
⎝
⎜⎜⎜⎜
⎞
⎠
⎟⎟⎟⎟⎟
θ
σ
θ
σ
, , ,
2 2
 and  
where θd is the population mean change in disease for 
farms with an intervention in place, θc is the same pa-
rameter but for the control farms, and σd
2 is the popula-
tion variance for the disease and is assumed to be the 
same for both control and intervention farms. Subscript 
d is used to refer generally to the diseases: d = m, l, j 
for mastitis, lameness, and Johne’s disease, respectively.
The parameter of interest was the difference in the 
population mean change in disease: θd – θc. A point 
estimate for this difference from the trial data can be 
obtained using y y yd c= − , and the normal likelihood is 
given by
 y N
n nd c
d d≈ − +
⎛
⎝
⎜⎜⎜⎜
⎞
⎠
⎟⎟⎟⎟⎟
θ θ
σ σ
, ;
2 2
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 that is; y N
nd
d≈
⎛
⎝
⎜⎜⎜⎜
⎞
⎠
⎟⎟⎟⎟⎟
θ
2σ
, ,
2
 [3]
because, in keeping with the condition used for eliciting 
the veterinarians’ beliefs, θc is assumed to be zero for 
each disease. Veterinarians’ clinical expectations were 
elicited for θd given θc = 0, and because normal distri-
butions were fitted to their beliefs, the priors took the 
form
 p di
di di
di
θ
θ ϕ
τ
( ) ∝ −
−( )⎛
⎝
⎜⎜⎜⎜⎜⎜
⎞
⎠
⎟⎟⎟⎟⎟⎟
exp ,
1
2
2
2
 
where i denotes the veterinarian and takes values i = 1, 
…, 94 (94 veterinarians were interviewed), and ϕdi  and 
τdi are the fitted hyperparameters (mean and standard 
deviation) for each veterinarian. With the normal likeli-
hood specified by Equation [3]; that is,
 y
y n
d
d
d
| exp ,θ
θ
2σ
∝ −
−( )⎛
⎝
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⎞
⎠
⎟⎟⎟⎟⎟⎟
1
2
2
2
 
the Bayesian analysis (i.e., Equation [1]) is conjugate, 
and it can be shown (Spiegelhalter et al., 2004) that the 
posterior distribution also takes the shape of a normal 
distribution, as follows:
 θdi
di
di d
di d di d
y N
yn
n n
| ,∼
ϕ
τ 2σ
τ 2σ τ 2σ
2 2
2 2 2 2
1
1
1
+
+ +
⎛
⎝
⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜
 
⎜
⎞
⎠
⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟
. [4]
In combination with the elicited values for θd
min and 
λd, Equation [4] can be used to explore the implications 
of the heterogeneity in veterinarians’ clinical expecta-
tions because it provides the formula to calculate the 
posterior distribution (i.e., the predicted belief) for 
each veterinarian and for each disease.
In Equation [4], ϕ
di
 and τdi were derived from the raw 
elicitation data (obtained during the interviews), and 
the remaining variables y n d, ,  σ
2( ) require specification. 
The value chosen for y (i.e., the difference in the sample 
means between the control and intervention farms in 
the trial) was the median value (i.e., across the 94 par-
ticipating veterinarians) of the median clinical expecta-
tion for θd. For each disease, the population variance σd
2 
is unknown and therefore sensitivity of the results to 2 
choices were explored: σd = 10% and 25% for d = m, l, 
j. As n is the number of farms in each arm of the trial, 
2n is the total size of the clinical trial and was given 
values of 20, 50, 100, and 200 farms. For clinical de-
mands, because θd
min was elicited from each veterinari-
an, the median value (across all veterinarians) was 
used; note that because a few veterinarians elected to 
give a range of values, the lower value of the range was 
taken to calculate the median clinical demand. As de-
scribed, this Bayesian model explores how large a clini-
cal trial would be required to convince the most pessi-
mistic veterinarian that the median clinical demand of 
this sample of veterinarians will be exceeded. It also 
explores, theoretically, how large a clinical trial would 
be required to bring the most pessimistic and most en-
thusiastic veterinarian into general agreement; that is, 
assuming veterinarians revise their beliefs logically in 
keeping with Bayes theorem. As explained, the model 
makes some assumptions regarding the data produced 
by a new clinical trial.
RESULTS
Response Rates and Description of Participants
Not all the veterinarians in one initially selected vet-
erinary practice agreed to participate; another practice 
was selected from the same region and consented. From 
the 20 consenting practices, 94 of the 96 selected vet-
erinarians were interviewed (2 were unavailable during 
the data collection period). Of the 20 practices, 7 were 
located in the North, 2 in the Midlands, and 11 in the 
South of England.
The data set included 36 partners and 58 assistants; 
sex was split 59 males to 35 females; and years qualified 
ranged from 0 to 37 yr, with a median of 7 yr. Of the 
94 veterinarians, 19 (20%) held a postgraduate cattle 
qualification. Time spent working with dairy cows was 
as follows: 6 participants spent 0 to <25% of their 
time, 16 participants 25 to <50%, 27 participants 50 to 
<75%, and 45 participants 75 to <100%.
Elicited Clinical Beliefs
Descriptive statistics concerning the raw elicited pa-
rameters θd are provided in Table 1. For each disease 
and each veterinarian, their raw elicited plausible range 
and median values for θd are presented in Figure 1, 
along with θd
min.
In Figure 2, the fitted normal distributions are plot-
ted for the most ambivalent, enthusiastic, pessimistic, 
and “average” veterinarian. For example, Figure 2B 
shows that the most pessimistic veterinarian concern-
ing the 3-yr lameness intervention had a normal distri-
bution centered at an 11% population mean reduction 
in lameness prevalence with a 95% credible interval of 0 
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to 21%, whereas the most enthusiastic veterinarian was 
centered at a 58% reduction with a 95% credible inter-
val of 38 to 78%; thus the enthusiastic veterinarian had 
a more uncertain belief (wider credible interval) com-
pared with the most pessimistic veterinarian. Figures 
1 and 2 together show the considerable heterogeneity 
in veterinarians’ clinical expectations, both in terms of 
central location and clinical confidence. The diversity 
in opinion was greater for the Johne’s disease interven-
tion compared with the other diseases, as highlighted 
by the marked polarization in beliefs displayed by the 
most enthusiastic and pessimistic veterinarians (Figure 
2C).
Across the 94 veterinarians, the median clinical de-
mand was a 20% population mean reduction in incidence 
for a 1-yr mastitis intervention with an interquartile 
range of 10 to 25%, a 20% reduction in mean prevalence 
for a 3-yr lameness intervention (interquartile range 
10–30%), and a 35% reduction in mean prevalence for 
an 8-yr Johne’s disease intervention (interquartile range 
25–50%). Comparing these figures with Table 1, it can 
be seen that the median clinical demand was below the 
median clinical expectation for all 3 diseases.
Figure 3 shows how each veterinarian’s clinical de-
mand compared with their median (best guess) clinical 
expectation; that is, whether each of the crosses (Fig-
ure 1) was below, above, or in the same place as the 
corresponding dot. It reveals that for both the mastitis 
and lameness interventions, most veterinarians (≥79%) 
had clinical demands that were lower than their me-
dian expectations. In contrast, for Johne’s disease, only 
51% of veterinarians had clinical demands that were 
lower than their median expectation; that is, there was 
more pessimism in terms of the effect that veterinarians 
clinically wanted and what they expected to happen for 
Johne’s disease compared with mastitis and lameness.
The summary statistics for veterinarians’ values for 
λd; that is, the probability they would require (as a 
percentage chance) that the mean reduction would be 
at least their own estimate for θd
min, were similar for 
each disease intervention and are as follows. Median 
values: λm = λl = λj = 80%; lower quartile λm = λl = 
λj = 75%; upper quartile: λm = 88%, λl = λj = 90%.
The distributions and summary statistics for vet-
erinarians’ estimates of the percentage of farmers who 
they believed would implement none of the disease 
interventions to any effective extent, despite initially 
agreeing to participate, are provided in Figure 4.
Modeling the Implications  
of the Heterogeneity in Beliefs
Figure 5 predicts (using Equation [4]) how the vet-
erinarian with the most pessimistic clinical expectation 
and the veterinarian with the most enthusiastic clinical 
expectation, regarding the lameness intervention, would 
update their expectations in light of new (synthetic) 
clinical trial data of different strengths. In Figure 5, 
the 4 plots (A to D) show the effects of clinical tri-
als of different sizes, involving 20, 50, 100, and 200 
farms in total. For each clinical trial, it was assumed 
that the data provided a point estimate, y, equal to a 
30% mean reduction in lameness prevalence in favor 
of the intervention farms (over the control farms), and 
that the population variance, σd, was 25%. Hence, the 
only difference between the clinical trials is that they 
are increasing in size, and because the likelihood is 
encapsulating the information arising from the clinical 
trial, it can be seen that the evidence from the trial 
becomes stronger (i.e., narrower and taller) from plot 
(5A) through to plot (5D) as the trial increases in size, 
but remains centered at 30%.
On each plot in Figure 5, normal distributions have 
been fitted to the elicited values belonging to the most 
pessimistic and enthusiastic veterinarians and reflect 
their current clinical expectations (priors), as they stat-
ed during their interviews; that is, the “prior enthusiast” 
and “prior pessimist” curves. The plots show how the 
priors are updated when combined with the likelihood 
(i.e., the new data) using Bayes theorem. Hence the 
“updated enthusiast” and “updated pessimist” curves 
are the posterior distributions and represent what the 
Table 1. The elicited clinical expectations of 94 veterinarians for the population mean effect of a disease 
intervention1 
Elicited value
Population mean reduction (%)
Mastitis  
incidence
Lameness  
prevalence
Johne’s disease  
prevalence
Minimum 10 (5–15) 10 (5–20) 10 (5–30)
Lower quartile 24 (17–33) 24 (15–35) 33 (20–50)
Median 30 (20–40) 30 (20–40) 40 (30–60)
Upper quartile 36 (25–46) 39 (25–50) 52 (38–65)
Maximum 50 (40–60) 50 (40–65) 70 (50–80)
 1Values shown are median (interquartile range).
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most pessimistic and enthusiastic veterinarian are pre-
dicted to believe if they had been shown the clinical 
trial data, and updated their opinions coherently in 
accordance with Bayes theorem. To emphasize, the vet-
erinarians were not shown any data during their inter-
views, and the posterior distributions shown in Figure 5 
are predictions arising from the Bayesian models.
Across the 94 veterinarians, the median clinical de-
mand for the 3-yr lameness intervention was a 20% 
mean reduction in prevalence, shown in Figure 5 by the 
straight vertical line. Plot 5A shows that in light of a 
clinical trial involving 20 farms, the most pessimistic 
veterinarian is predicted to believe that there will only 
be an 0.11 probability (11% chance) that this clinical 
demand will be exceeded (area under the “updated pes-
simist” curve to the right of the vertical 20% line, as a 
proportion of the total area under the curve). As the 
size of the clinical trial increased, the most pessimistic 
veterinarian was predicted to become more convinced 
that this goal would be realized, such that with a trial 
Figure 1. The clinical expectations of 94 veterinarians concerning the population mean reduction in disease achievable with (A) a 1-yr masti-
tis intervention, (B) a 3-yr lameness intervention, and (C) an 8-yr Johne’s disease intervention; median beliefs (dots) and plausible range (lines). 
Crosses (x) denote the minimum clinically worthwhile reduction stipulated by each veterinarian (i.e., the clinical demand). For each disease, 
veterinarians were ordered along the x-axis by their median belief (dots). Color version available in the online PDF.
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involving 200 farms, they were predicted to believe that 
there was a 0.92 probability that this clinical demand 
would be exceeded (plot 5D).
The null hypothesis is usually rejected in favor of 
the alternative hypothesis when the posterior distribu-
tion assigns a “sufficiently large” probability to θ taking 
values greater than θmin; because this probability (λ) is 
often taken to be ≥0.95, then, on this basis, a 200-farm 
clinical trial is not strong enough evidence to convince 
a “reasonable skeptic” (i.e., the most pessimistic veteri-
narian in this sample) that the intervention is clinically 
worthwhile. However, for the lameness intervention, the 
majority of veterinarians interviewed provided a value 
for λl that was <0.90 (upper quartile λl = 90%), and 
therefore on this basis, a clinical trial of 200 farms may 
be expected to be sufficiently convincing to the major-
ity of veterinarians who participated in this study.
Figure 5 also shows how the most enthusiastic vet-
erinarian is predicted to have their enthusiasm damped 
by the trial results. The most enthusiastic veterinarian 
was expecting a mean reduction in prevalence centered 
in the region of 60% (“prior enthusiast” curve), and 
for example, plot 5C shows that this is predicted to 
be reduced to a more confident belief that is centered 
around a 35% reduction (“updated enthusiast” curve) 
with a 100-farm trial.
Figure 5C also shows that in the light of the evidence 
originating from a 100-farm trial, the most pessimistic 
and enthusiastic veterinarians are predicted to have up-
dated beliefs that are still almost entirely in disagree-
ment (updated curves barely overlapping).
In plots A to D (Figure 5), the population stan-
dard deviation σl was assumed to be 25%. For a given 
size of clinical trial, taking σl to be 10%, results in a 
stronger likelihood (because there is less variation of 
farms around the mean value), and therefore affects 
the analysis. Plots E to H (Figure 5) show an identical 
analysis to plots A to D (Figure 5), but with σl assumed 
to be 10%. It shows that because the evidence from the 
trial is stronger, a 50-farm trial is predicted to convince 
(with a 0.99 probability) the prior pessimist that a 20% 
mean reduction in lameness prevalence will be realized.
A similar analysis to that presented in Figure 5 
was run for the mastitis and Johne’s disease interven-
tions; for the mastitis intervention, the median clinical 
demand was 20% (the same as for the lameness in-
tervention) and for Johne’s disease, it was 35%. For 
the mastitis intervention, the synthetic trial data were 
Figure 2. Normal probability distributions fitted to the elicited 
clinical expectations (θd) belonging to the most ambivalent, enthu-
siastic, pessimistic, and “average” veterinarians: (A) a 1-yr mastitis 
intervention, (B) a 3-yr lameness intervention, and (C) an 8-yr Johne’s 
disease intervention.
Figure 3. Each veterinarian’s clinical demand, θd
min, compared 
with their median (best guess) for the expected clinical outcome θd.
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set to provide a point estimate of a 30% reduction in 
clinical mastitis incidence, and for Johne’s disease, a 
40% reduction in prevalence (these figures were the 
median expected reduction in disease elicited across the 
94 veterinarians, Table 1). The analyses were run for 
population standard deviations of 10% and 25% and, 
for each disease, the predicted probability of exceeding 
the median clinical demand in light of the clinical trial 
data was calculated for the most pessimistic veterinar-
ian. The results are presented in Table 2, where the 
lameness results from Figure 5 have also been included 
to allow comparison.
Figure 2 shows that the most pessimistic veterinar-
ian for the mastitis intervention (plot A) was more 
confidently pessimistic (narrower and taller distribu-
tion) compared with the most pessimistic veterinarian 
for the lameness intervention (plot B); consequently, 
as Table 2 reveals, this veterinarian needs stronger 
evidence, according to Bayes theorem, to be convinced 
that the clinical demand will be exceeded. Thus, the 
most pessimistic veterinarian concerning mastitis inter-
vention is predicted to be entirely unconvinced, even by 
a trial involving 200 farms (if the population standard 
deviation is indeed 25%) because they are predicted 
to give only a 12% chance that a 20% reduction in 
mastitis will be achieved. This is demonstrably differ-
ent from the most pessimistic veterinarian concerning 
the lameness intervention, who would be substantially 
convinced by a 200-farm trial (0.92 probability), with 
the same population variance assumption.
DISCUSSION
The results revealed that markedly different clinical 
opinions currently exist; hence, for all 3 disease inter-
ventions, a major change in clinical expectations would 
be required to bring the most enthusiastic and most 
pessimistic veterinarians into clinical agreement. It 
may not be desirable for veterinarians to be completely 
united in their clinical beliefs, but broad agreement for 
the major endemic diseases is important both for the 
credibility of the profession and to provide a unified 
approach to disease control. The wide heterogeneity 
observed raises concerns over the extent to which a 
broadly consistent approach to controlling these en-
demic diseases is currently being achieved. This in 
turn supports the argument for the implementation of 
national disease control programs for nonstatutory en-
demic diseases. This is because national disease control 
programs help to provide a coordinated and consistent 
approach to disease control. As the variability between 
veterinarians increases, the potential gain derived from 
implementing a national disease control program also 
increases.
Explanation for the observed heterogeneity in clinical 
expectations is likely to be multifactorial. In this regard, 
the paucity of literature quantifying the effects of these 
interventions is worth noting. To our knowledge, only 
1 randomized clinical trial has estimated the effect of a 
clinical mastitis intervention of the type described here 
(Green et al., 2007); this 1-yr intervention study found 
a 22% reduction in the proportion of cows affected with 
clinical mastitis on the intervention farms compared 
with the control farms. There appears to be an absolute 
lack of randomized clinical trials estimating the effects 
of lameness and Johne’s disease interventions. More 
Figure 4. Veterinarians’ estimates for the percentage of dairy 
farmers who, having agreed to undertake a structured disease inter-
vention and had an initial visit, subsequently fail to implement any 
of the required changes to any successful extent: (A) a 1-yr mastitis 
intervention, (B) a 3-yr lameness intervention, and (C) an 8-yr Johne’s 
disease intervention.
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Figure 5. A Bayesian analysis to predict how the most pessimistic and enthusiastic veterinarians regarding the 3-yr lameness intervention, 
would update their clinical opinions in light of new synthetic trial data of different sizes. For plots A to D, the population standard deviation 
(SD) was assumed to be 25%; for plots E to H, SD = 10%. In each plot, the trial data (likelihood) was assumed to provide a point estimate 
equal to a 30% mean reduction in lameness prevalence. “Updated enthusiast/pessimist” is the posterior distribution obtained by combining the 
relevant prior belief with the likelihood using Bayes theorem. “Clinical demands” (= 20%) is the median “minimum clinically worthwhile reduc-
tion” elicited across the 94 veterinarians. The probability (P) that the “updated pessimist” assigns to this value being exceeded is given (area 
under the curve to the right of the straight vertical line). Color version available in the online PDF.
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clinical trials to quantify the effects of intervention 
strategies to reduce the major endemic diseases of dairy 
cattle are required because there is a lack of knowledge 
in this area. In our data set, we did not find any sta-
tistically significant differences in veterinarians’ beliefs 
by the following factors: time spent working with dairy 
cows, possession of postgraduate qualifications or not, 
job status (assistant vs. partner), or sex of respondent. 
However, this is not to say that these factors are not 
associated with different opinions.
Notably, clinical expectations were elicited condition-
al on an assumption that the population mean change 
in disease would be zero in the absence of a disease 
intervention; it is necessary to know what veterinar-
ians were basing their clinical expectations for a disease 
intervention against. It is acknowledged that some may 
believe this to be a larger assumption to make for the 
Johne’s intervention compared with the mastitis and 
lameness interventions. We made this assumption for 
the purpose of simplicity and in the absence of any 
data.
The results also showed considerable variation in 
veterinarians’ estimates for the percentage of farmers 
who would not effectively implement any of the inter-
vention to any extent, despite initially agreeing to do 
so. The median estimates were nontrivial percentages: 
20, 24, and 30% for the mastitis, lameness, and Johne’s 
disease interventions, respectively. This may, in part, 
reflect veterinarians’ practical experiences with main-
taining farmer engagement with a disease intervention. 
Understanding ways to facilitate and support farmers 
to make the changes needed to implement a disease 
intervention is important.
“Clinical demands” in a herd health context could be 
interpreted in 4 different ways. First, the reduction the 
veterinarian would want to consider the intervention 
clinically worthwhile. Second, what the veterinarian 
thinks the farmer would want to hear to be convinced 
enough to implement the intervention. Third, what 
the farmer would actually demand to be prepared to 
implement the intervention, with its associated time, 
financial, and labor investments. Fourth, the reduc-
tion the veterinarian needs to consider the intervention 
clinically worthwhile solely from the perspective of 
their patient; that is, the cow. In a sense, the latter is 
analogous to the scenarios for which clinical demands 
have been elicited and reported in human medicine, 
where the doctor is faced with deciding what is best for 
their patient, given the treatment will be freely avail-
able and the patient will almost certainly take it.
In this study, it was stipulated that clinical demands 
related to the first point only. However, it may be dif-
ficult to compartmentalize these issues. Thus, part of 
the variation in veterinarians’ clinical demands may 
have related to how they chose to weigh the vested 
interests of all stakeholders; for example, veterinarians 
who estimated a very small clinical demand may have 
given greatest weight to the interests of the cow, or to 
the environment, whereas those who gave the highest 
clinical demands may have given more weight to the 
financial cost-effectiveness for the farmer. Another pos-
sible explanation for the variation in clinical demands 
may concern differences between veterinarians in terms 
of their beliefs about the economic benefits of control-
ling the different diseases. This may, in turn, reflect 
differences in undergraduate teaching between universi-
ties.
It is important to note that the Bayesian analysis 
presented here has modeled the effect of new clinical 
trial data on veterinarians’ current opinions, assuming 
they would update their beliefs logically in accordance 
with Bayes theorem. This means that as the size of the 
trial increases, the mathematical model predicts that 
veterinarians will become more convinced because the 
evidence from larger trials is stronger. However, contro-
versy currently exists in the literature over the extent 
to which people are actually able to logically value, in-
terpret, and revise their opinions when presented with 
new information (Tversky and Kahneman, 1974; Kynn, 
2008; Westover et al., 2011). Recent findings suggest 
that people can update their beliefs in a Bayesian man-
ner, but how the task is framed is important (Giger-
Table 2. The predicted probability of exceeding the median clinical demand (20% mastitis, 20% lameness, 
35% Johne’s disease) for the most pessimistic veterinarian, when their prior clinical expectation is combined 
with synthetic trial data of different sizes using Bayes theorem; the trial data provided a point estimate of 
a 30% reduction in clinical outcome for mastitis and lameness, and 40% for the Johne’s disease intervention 
Disease  
intervention
Population 
SD (%)
Size of randomized clinical trial (no. of farms)
20 50 100 200
Mastitis 10 0.02 0.43 0.97 1.00
25 <0.001 0.001 0.01 0.12
Lameness 10 0.73 0.99 1.00 1.00
25 0.11 0.29 0.61 0.92
Johne’s disease 10 <0.001 0.037 0.41 0.94
25 <0.001 <0.001 <0.001 0.003
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enzer and Edwards, 2003; Gigerenzer and Hoffrage, 
2007). In reality, it may be challenging for veterinarians 
to differentiate between evidence of varying strength 
and quality. Other factors, such as the perceived repu-
tation of the scientists conducting the work, the final 
concluding remarks of the paper, or the point estimate 
alone (not in combination with the confidence or cred-
ible interval) may be more influential. More research is 
needed to establish how logically veterinarians update 
their beliefs about clinical parameters, using informa-
tion published in veterinary journals. This is important 
to ascertain, because investing money in larger clinical 
trials to convince skeptical clinicians will not provide 
a return unless they revise their beliefs in at least a 
somewhat logical manner. And, of course, due consid-
eration should be given to all the other factors that 
influence veterinary beliefs and other approaches em-
ployed as necessary. This could include communication 
strategies, as well as helping veterinarians to interpret 
new information appropriately, and facilitating and im-
proving veterinary education (both undergraduate and 
postgraduate).
It is also worth noting that, in human medicine, λ 
has not been elicited from doctors, even though doc-
tors’ clinical demands have been elicited. A choice for 
λ that is less than 0.95 may not be generally accept-
able to the scientific community, because it may not be 
regarded as robust enough evidence. However, it is a 
subjective choice and clinically useful information may 
go unreported if only clinical trials achieving λ ≥0.95 
are published.
A potential limitation of this study is the repeat-
ability of the results at a later date in the absence of 
any genuine change in veterinarians’ beliefs. There is 
no literature reporting the repeatability of the method. 
However, during the interviews, extra clarification was 
given if required. This reduced misunderstanding, which 
is one reason why different results may be obtained on 
different dates.
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APPENDIX
Standard Elicitation Script
Clinical Expectations: Mastitis Intervention. 
My first question is about a clinical mastitis interven-
tion and how successful you think it might be when 
implemented on a large number of dairy farms.
Please imagine that all the dairy farms in England 
are visited by their own local veterinarian today, spe-
cifically to discuss their current clinical mastitis situ-
ations. As a result, we have identified a large number 
of farms, for which both the farmer and their local vet 
have agreed there is a clinical mastitis problem and 
they have decided that the farmer will go ahead with a 
structured clinical mastitis intervention with the help 
of their local vet over the next year.
By a structured clinical mastitis intervention over the 
next year, I mean the following:
Initially, the vet tries to identify the main cause (s) of 
the mastitis problem. The vet carries out some strategic 
laboratory testing, assesses any available milk recording 
data and any other relevant farm data that is available 
(e.g., clinical mastitis records). The vet then makes a 
specific visit to walk round the farm and assess the 
risks that may be contributing to the problem. The vet 
quantifies the risks using our current best evidence for 
clinical mastitis. As a result the vet produces a list of 
recommendations, prioritizes them and discusses them 
with the farmer. Over the next year, the vet revisits the 
farm at least every quarter, reassesses any data avail-
able and the on-farm risks, and modifies the recom-
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mendations as necessary. These are discussed with the 
farmer, and the vet supports and encourages the farmer 
to implement the required changes. This approach, over 
a year, is what I mean by a “structured clinical mas-
titis intervention.” Note: the recommendations can be 
anything, including major farm reinvestment, but the 
vet is realistic and will not make suggestions that will 
outstrip the current labor and capital resources of this 
particular farm.
When we think about this large number of farms, 
despite the fact that the farmers have all decided to 
implement a mastitis intervention and they have all 
had a first initial visit by their vet, nevertheless some 
of them may not actually implement any of the recom-
mendations either at all or sufficiently well over the 
year, such that their intervention had no chance of hav-
ing any effect at all simply due to farmer compliance.
Question: What is your best estimate for the per-
centage of farms that, in reality, would fall into this 
category?
Now we are going to think about how successful the 
mastitis interventions will be on average, across all the 
farms. However, when doing this we are going to exclude 
the farms we have just talked about; that is, those who 
will do nothing or so little that their interventions have 
no chance of working at all.
[Scale:] We will be working in terms of the percentage 
reduction (or percentage increase) of the original masti-
tis problem. By this I mean that in the year before we 
start the mastitis intervention, we have measured (for 
each farm) the number of clinical cases of mastitis per 
100 cows per year. And in the year after the interven-
tion, we will again measure the number of clinical cases 
of mastitis per 100 cows per year. So for example, a 
50% reduction in the farms original clinical mastitis 
problem means that a farm with 120 clinical cases per 
100 cows occurring in the year before the intervention 
would have 60 clinical cases per 100 cows in the year 
after the intervention. Do you have any questions about 
this?
If we don’t intervene, we will assume that the masti-
tis problems on the farms will not change on average.
Range: It is natural that you will have some uncer-
tainty about the average effect of the mastitis inter-
vention. Therefore, please can you give me a plausible 
range for the average effect, as a percentage increase 
or reduction of the original clinical mastitis problem? 
That is, tell me the worst (X) and the best (Y) possible 
answer for the average, such that you think it exceed-
ingly unlikely that the actual answer could turn out to 
fall outside of this range?
Take time to think about your answer. Feel free to 
ask any questions or talk it through.
So, your plausible range for the average effect of a 
mastitis intervention is between X and Y. Please take 
time to consider if this properly reflects the amount of 
uncertainty you have in what the average effect of this 
mastitis intervention might be? You can revise your 
answer if you wish. Note that the more uncertainty you 
have, the wider your range should be.
Median: Given your range, please tell me your “best 
guess” (median value, M) for the average effect of the 
clinical mastitis intervention. This should be a value 
such that you believe it is just as likely that the true 
answer will turn out to fall somewhere between your 
worst possible value (which was X) and this number, 
and this number and your best possible value (which 
was Y). Please let me know if you have any queries 
about this.
Lower and upper quartiles: Please can you give me a 
value for your lower quartile for the average effect. This 
is a number such that you think it is equally likely that 
the actual answer will fall between your worst possible 
value (X) and this value, and this value and your best 
guess (which was M). Please let me know if you have 
any queries about this.
Please can you give me a value for your upper quar-
tile for the average effect. This is a number such that 
you think it is equally likely that the actual answer will 
fall between your best guess (which was M) and this 
value, and this value and your best possible answer 
(which was Y). Please let me know if you have any 
queries about this.
Fitted probability distribution: [Researcher fits prob-
ability distribution to the 5 values (range, median, 
lower and upper quartile) and produces a graph using 
SHELF software. The graph is shown to veterinarian 
(with explanation). The fitted probabilities are com-
pared with the elicited values. Researcher feeds back 2 
implied probabilities (10th and 90th percentiles) from 
the fitted distribution].
Does the shape and distribution of this graph repre-
sent what you believe? (yes/no)
[If yes, proceed. If no, invite them to vary some values 
to fit others that are believed to be more pivotal. Re-fit 
a new distribution and feedback until the veterinarian 
is satisfied that the distribution is an accurate reflec-
tion of their belief.]
Clinical Demands: Mastitis Intervention. So 
far, we’ve discussed what we expect might actually 
happen if we were to implement a clinical mastitis in-
tervention on a large number of dairy farms, in terms 
of the average effect. For my next question, I just want 
a single answer and it has nothing to do with what 
we’ve said previously about what we are expecting to 
happen!
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We are interested in what you want the average re-
duction in clinical mastitis to be, in order for you to feel 
that the intervention itself typically provides what you 
consider a clinically worthwhile and important reduc-
tion and therefore should be implemented on a large 
number of farms.
Rolling out an intervention onto thousands of farms 
has costs to the whole industry but also benefits. This 
question is about weighing up all the costs and all the 
benefits.
If I told you that the average effect of a mastitis 
intervention is an increase in the original disease prob-
lem, say 10% on average, we wouldn’t consider it a 
good intervention! Similarly if I told you that the aver-
age effect of a mastitis intervention is zero change on 
average, we wouldn’t consider it a good intervention!
For this 1-yr clinical mastitis intervention, please tell 
me, what is the minimum that you would want the 
average reduction in clinical mastitis to be in order for 
you to feel that the mastitis intervention itself is clini-
cally useful when implemented on a large number of 
farms? This can just be a single answer (or you can give 
me a range if you prefer).
In reality, all researchers can do is estimate the aver-
age effect of a mastitis intervention when implemented 
on a large number of farms, by carrying out a clinical 
trial. They would implement the mastitis intervention 
on a small number of farms and compare the average 
reduction observed to a small number of control farms. 
Hence, researchers cannot prove to us with absolute 
certainty that the average reduction will definitely be 
greater than what you wanted. There will always be 
some uncertainty.
λ: My next question is about how certain you per-
sonally would need to be (as percentage chance), that 
the average reduction is going to be at least what you 
said you wanted, in order that you personally would be 
convinced that the mastitis intervention is useful and 
worthwhile implementing on many farms, based on the 
results of a clinical trial alone.
By this I mean that if you considered the evidence 
that some researchers had produced, and as a result 
you are now sure enough that the average reduction is 
going to be at least what you wanted, then you would 
be convinced that the mastitis intervention is clinically 
useful. How sure would you personally need to be (as 
a percentage chance) in order for you to be convinced 
that the mastitis intervention is clinically useful and 
worthwhile implementing on many farms?
My next 2 questions are identical in format to this 
clinical mastitis intervention question, except that they 
relate to a lameness intervention and a Johne’s disease 
intervention. Let’s start with lameness first.
Lameness Intervention
Repeat the above text, but substitute “lameness” for 
“clinical mastitis” and “ 3 years” for “1 year.” For the 
description of the structured lameness intervention, 
the text is modified to include mobility (locomotion) 
scoring the milking cows. For the scale, substitute the 
following text:
We will be working in terms of the percentage reduc-
tion (or percentage increase) of the original lameness 
problem. So at the start of the lameness intervention, 
we mobility (locomotion) score the entire herd for lame-
ness and hence we know, for every farm (reliably) what 
percentage of the herd is lame. Note: by “lame” we 
mean observably lame in one or more limbs, with any 
severity of limp. At the end of the 3-yr intervention, 
we will again mobility (locomotion) score the entire 
herd for lameness and hence we know, for every farm 
(reliably) what percentage of the herd is lame. So, for 
example, a 50% reduction in the farm’s original lame-
ness problem means that a farm with 40% of the herd 
lame has 20% of the herd lame after 3 yr.
Johne’s Disease Intervention
Repeat the above text, but substitute “Johne’s dis-
ease” for “clinical mastitis” and “8 years” for “1 year.” 
For the scale, substitute the following text:
We will be working in terms of the percentage re-
duction (or percentage increase) of the original Johne’s 
problem. So, we blood sample all the adult cattle (over 
24 mo old) and hence we will know, for every farm, 
what percentage of the adults are blood test positive for 
Johne’s at the start. After the end of the 8-yr interven-
tion, we will again blood test the adults and hence we 
know, for every farm, what percentage of the herd is 
blood test positive for Johne’s at the end. So for ex-
ample, a 50% reduction in the farms original Johne’s 
problem after an 8-yr Johne’s intervention means that a 
farm with 40% of adults testing positive for Johne’s at 
the start has 20% of adults testing positive after 8 yr.
